Sponsor:
Vanderbilt University Medical Center
Code:
NCT07529691
Conditions
Fibromuscular Dysplasia of Arteries
Fibromuscular Dysplasia
Spontaneous Coronary Artery Dissection
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Fibromuscular Dysplasia of Arteries
Fibromuscular Dysplasia
Spontaneous Coronary Artery Dissection
Study ID
NCT07529691
Start date
Apr 14, 2026
Status verified date
Apr, 2026
Completion date
Jun 30, 2027
Anticipated
Primary completion date
Apr 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
2000 participants
Anticipated
Arms
Patients with fibromuscular dysplasia
Primary outcome measure
Central contacts
Locations
Vanderbilt University Medical Center
Recruiting
Nashville, Tennessee, United States, 37232
Contacts
Principal Investigator:
Amanda M Morrison, MD
Sponsor
Vanderbilt University Medical Center
Last update posted
Apr 20, 2026
Last verified
Apr, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2026-04-20.